Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MNGIE (Mitochondrial Neurogastrointestinal Encephalomyopathy) AHSCT (Allogeneic Hematopoietic Stem Cell Transplant) Safety Study

NCT02427178 is registered in ClinicalTrials.gov with Michio Hirano, MD as lead sponsor.

NCT NCT02427178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02427178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MNGIE (Mitochondrial Neurogastrointestinal Encephalomyopathy) AHSCT (Allogeneic Hematopoietic Stem Cell Transplant) Safety Study
Lead sponsor
Michio Hirano, MD
Phase
Phase 1
Overall status
Withdrawn
Start date
March 31, 2015
Completion date
June 30, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mitochondrial neurogastrointestinal encephalomyopathy (mngie)